Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyadenomatoses: type 2 multiple endocrine neoplasms].

B Conte-Devolx1, P Niccoli-Sire,

  • 1Service d'Endocrinologie-Maladies Métaboliques, Hôpital de la Timone 13385 Marseille. bconte-devolx@aphm.fr

Presse Medicale (Paris, France : 1983)
|September 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.

European journal of endocrinology·2015
Same author

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.

European thyroid journal·2014
Same author

A conservative management is preferable in milder forms of pituitary tumor apoplexy.

Journal of endocrinological investigation·2010
Same author

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2010
Same author

Could primary hyperparathyroidism-related hypercalcemia induce hypercalcitoninemia?

Hormone research in paediatrics·2010
Same author

Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.

The Journal of clinical endocrinology and metabolism·2009
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Early diagnosis of Multiple Endocrine Neoplasia type 2 (MEN2) is crucial for improving prognosis. Identifying RET gene mutations enables early screening and treatment of associated endocrine tumors like medullary thyroid carcinoma.

Area of Science:

  • Endocrinology
  • Genetics
  • Oncology

Background:

  • Multiple Endocrine Neoplasia type 2 (MEN2) is an inherited disorder characterized by multiglandular involvement.
  • Medullary thyroid carcinoma (MTC) is a hallmark of MEN2, often accompanied by pheochromocytoma and hyperparathyroidism.

Purpose of the Study:

  • To highlight the critical role of early diagnosis in managing MEN2 prognosis.
  • To emphasize the significance of RET gene mutations in identifying at-risk individuals.

Main Methods:

  • Genetic analysis to detect RET proto-oncogene mutations.
  • Screening protocols for early detection of endocrine damage in familial carriers.

Main Results:

  • Identification of RET mutations allows for precise risk assessment within families.

Related Experiment Videos

  • Early biological and clinical screening can detect endocrine lesions before manifestation.

    • Conclusions:

    • Genetic screening for RET mutations is essential for early diagnosis and intervention in MEN2.
    • Proactive management based on genetic identification improves outcomes for MTC and other associated conditions.